Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-21-008045

Chief Financial Officer acquired 1,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moretti August J · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-04-12 Exercise or conversion : show line 1 in the form +1,000 $9.41 $9,410 2,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-12 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −1,000 223,060 D
Loading xslF345X03/doc1.xml…